Your weekly roundup of the latest news from Drug Topics®.
The pipeline includes next-in-class treatments for melanoma, NSCLC, breast cancer, and multiple myeloma.
A do-it-yourself option to replace traditional diabetes management technology is growing in popularity.
Transformation was top of mind at the 2022 American Associated Pharmacies (AAP) Annual Conference, where industry leaders, pharmacy owners, and AAP staff came together to celebrate their first annual meeting—live and in-person—since 2019.
The drug has previously been approved to treat moderately to severely active rheumatoid arthritis.
Patient reported outcomes for were positive for those who filled medications at an integrated health system specialty pharmacy.